Today marks the first official agency warning about the possibility of these drugs—specifically Mounjaro—decreasing the ...

Growing At-Home Men's Health Program in North America-PeterMD's Telemedicine Clinic Offers Transparent, Doctor-Supervised TRT ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...